Cam Bioceramics sold its Chinese activities to Orchid Orthopedic Solutions
Cam Bioceramics sold its Chinese production facility and operations (Cam China) to Orchid Orthopedic Solutions (Orchid). With the acquisition of Cam China, Orchid further strengthens its role as a global coating leader for the orthopaedic and medical device industry.
Cam Bioceramics (www.cambioceramics.com) is a global orthobiologic materials innovator specialising in calcium phosphates based in the Netherlands. By divesting its Chinese coating facility to Orchid, Cam Bioceramics is focusing on its core business: the engineering, development and contract manufacturing of orthobiologic calcium compositions.
Orchid (www.orchid-ortho.com), headquartered in the United States, is a worldwide leader in design and manufacturing for the orthopaedic and medical device industry. With over 1,800 plus-skilled employees and fifteen production facilities, Orchid generates a turnover of around EUR 270 million.